GOES LIVE ON October 26, 2020

OncoGenerix (Buyout Offering SPV2)

DEAL PENDING; Pharma Production

Reg D 506(c)
Accredited Investors Only?
SEC regulations limit certain types of investments to "accredited investors" only. The criteria below will help us determine if you are accredited (according to SEC regulations) to invest in our ventures
$0 | % Equity Share
ONGXE2 Share Price - $1,000.00
Minimum Investment:
$1,000

Project Summary

Deal Pending. OncoGenerix is a fully integrated new generation manufacturer of sterile and aseptic injectable drugs, focused on most complex and highly potent oncology-related formulations. Having completed required manufacturing certifications, OncoGenerix is now aggressively ramping up its production pipeline. To do so, OncoGenerix has a substantial full-time merchandising and marketing presence in Europe and the United States and is developing business worldwide via distribution agreements with some of the …
To view full page please Log In or Get Started
To view this page please Log In or Get Started
To view this page please Log In or Get Started
To view this page please Log In or Get Started
To view this page please Log In or Get Started
Log In

Wait, please...

Loading...

If you forgot your password you can reset it.

Reset password
Step 1/2
Please fill out your email. A token to reset password will be sent there.
Step 2/2